Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma.
Fukuhara N, Nishiyama M, Iwasaki Y.
Cancers (Basel). 2022 Jul 24;14(15):3604. doi: 10.3390/cancers14153604.
Hyperprolactinaemia and galactorrhoea with combined oral contraceptive pill use: A refresher.
Choy KR, Wong A.
Aust J Gen Pract. 2022 Jun;51(6):423-424. doi: 10.31128/AJGP-07-21-6068.
Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review.
Fattahi AS, Amini G, Sajedi F, Mehrad-Majd H.
Breast J. 2023 Sep 26;2023:9947797. doi: 10.1155/2023/9947797. eCollection 2023.
Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.
Chen H, Fu J, Huang W.
Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD008883. doi: 10.1002/14651858.CD008883.pub2.
[Prolactinoma].
Glezer A, Bronstein MD.
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):118-23. doi: 10.1590/0004-2730000002961.
Effects of pregnancy, delivery and lactation in hyperprolactinemia with prolactin producing pituitary adenoma.
Kondo I, Suganuma N, Kimura T, Matsuzawa K, Osawa M, Masahashi T, Mizutani S, Narita O, Tomoda Y.
Nihon Sanka Fujinka Gakkai Zasshi. 1989 May;41(5):595-600.
Galactorrhea and hyperprolactinemia.
Sakiyama R, Quan M.
Obstet Gynecol Surv. 1983 Dec;38(12):689-700. doi: 10.1097/00006254-198312000-00001.
Advances in the treatment of prolactinomas.
Gillam MP, Molitch ME, Lombardi G, Colao A.
Endocr Rev. 2006 Aug;27(5):485-534. doi: 10.1210/er.2005-9998. Epub 2006 May 26.
The effects of combined bromocriptine and Bu-shen-zhu-yun decoction on serum hormones, anxiety, and pregnancy in hyperprolactinemic infertility patients.
Feng H, Zhong Q, Zhou H, Jiang X, Ding Y.
Ann Palliat Med. 2021 Dec;10(12):12230-12243. doi: 10.21037/apm-21-3111.
